Jeffrey Tyner, Ph.D.
- click here
"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia,"
"Belinostat and panobinostat (HDACI): In vitro and in vivo studies in thyroid cancer,"
"The PI3K/Akt1 pathway enhances steady-state levels of FANCL,"
"A case study of personalized therapy for osteosarcoma,"
"CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway,"